Wellbeing & Workforce

Veterinary team examining a dog

NAVTA Opens Nominations for 2026 Veterinary Technician of the Year Award

The National Association of Veterinary Technicians in America is accepting nominations for its 2026 Veterinary Technician of the Year Award, recognizing a credentialed veterinary technician for professional excellence, leadership and contributions to the profession. Nominations are due Nov. 6, 2026, at noon EST.

PetSmart Charities Launches Veterinary Fellowship to Expand Access to Care

PetSmart Charities has launched a veterinary fellowship program with five universities to prepare students for careers in community medicine. The organization projects the initiative could help develop 115 community-focused veterinarians by 2032 and ultimately support more than 550,000 additional veterinary visits annually.

VHMA Honors Passpaw Co-Founder Maria Morgan with Inaugural Kelly Clay Innovation Award

The Veterinary Hospital Managers Association (VHMA) has named Maria Morgan, MBA, CVPM, co-founder of Passpaw, as the inaugural recipient of the Kelly Clay Innovation Award. Morgan was recognized for developing a cloud-based platform that helps veterinary teams manage international pet travel requirements by streamlining compliance, reducing administrative workload, and improving the client experience.

Four Veterinary Professionals Named to LMU’s 2026 40 Under Forty Class

Lincoln Memorial University has recognized four alumni from its Richard A. Gillespie College of Veterinary Medicine as part of the university’s 2026 40 Under Forty program. The honorees—Dr. Daniel Doran, Mariel Hendricks, Dr. Jay Miles, and Dr. Mackenzie Treece—were selected for their professional achievements, leadership, service, and contributions to the veterinary profession.

Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer

Exubrion Therapeutics has promoted Gregory Taglialatela, MBA, to Chief Commercial Officer, where he will lead the company’s commercial strategy as it continues expanding access to Synovetin OA®, its injectable treatment for canine osteoarthritis. Taglialatela assumes responsibility for national sales, key account management, business development and strategic growth initiatives effective July 1, 2026.

Never Miss an Animal Health Story

Sign up for free to receive the latest veterinary news, product announcements, and industry developments.